New After Final Consideration Pilot Program (AFCP 2.0)

The USPTO recently announced an updated version of an earlier pilot program, seeking to find ways to reduce the number of Requests for Continued Examination...

USPTO’s Fee Schedule Effective March 19, 2013

The United States Patent and Trademark Office (USPTO) published its first Fee Schedule (click here to view) under the America Invents Act (AIA) that will...

PTO’s Final Rules on First Inventor to File Provisions Effective March 16, 2013

The PTO has issued proposed rules regarding implementation of the first inventor to file provisions of the AIA Patent Reform Act to take effect on...

Deadline of March 15, 2013, for Patent Applications to Avoid First-to-File Aspects of AIA

As a follow-up to our earlier newsletters regarding the changes in the patent laws under the America Invents Act (“AIA”), we remind you of the...

PTO’s Proposed Rules to Implement First Inventor to File Provisions of AIA

As a follow-up to our earlier newsletters regarding the changes in the patent laws under the America Invents Act (“AIA”), we remind you of the...

Final Rules In Effect as of September 16, 2012

Earlier this year we provided comments on the PTO’s proposed rules regarding the following provisions. The PTO has made those rules final for provisions that...

USPTO Starts New Pilot Program for Filing Information Disclosure Statements (IDS) After Payment of Issue Fee

The USPTO is implementing a pilot program (QPIDS program) intended to reduce pendency and applicant costs when an information disclosure statement (IDS) is filed after...

Patent Infringement provisions of Section 271 are not effective to prevent potential “off-label” sale of drug covered by method claims reciting approved use.

Once a drug has been approved by the Food and Drug Administration (FDA) for sale for one purpose, doctors can legally prescribe it for any...
1 7 8 9 10 11 12

Categories

Archive

MWZB Newsletter Signup

Subscribe